User profiles for J. Rayment

Juliet Rayment

Freelance Qualitative Researcher
Verified email at julietrayment.co.uk
Cited by 827

Disrespectful intrapartum care during facility-based delivery in sub-Saharan Africa: a qualitative systematic review and thematic synthesis of women's perceptions and …

S Bradley, C McCourt, J Rayment, D Parmar - Social science & medicine, 2016 - Elsevier
The psycho-social elements of labour and delivery are central to any woman's birth
experience, but international efforts to reduce maternal mortality in low-income contexts have …

Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective

…, JM Pilewski, L Quittell, JH Rayment… - The Lancet …, 2023 - thelancet.com
The growing use of modulator therapies aimed at restoring cystic fibrosis transmembrane
conductance regulator (CFTR) protein function in people with cystic fibrosis has fundamentally …

[HTML][HTML] Midwives' perspectives on (dis) respectful intrapartum care during facility-based delivery in sub-Saharan Africa: a qualitative systematic review and meta …

S Bradley, C McCourt, J Rayment, D Parmar - Reproductive health, 2019 - Springer
Background In the past decade, the negative impact of disrespectful maternity care on women’s
utilisation and experiences of facility-based delivery has been well documented. Less is …

A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele

…, P McNally, BW Ramsey, JH Rayment… - American journal of …, 2021 - atsjournals.org
Rationale: Elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) was shown to be efficacious and
safe in patients ≥12 years of age with cystic fibrosis and at least one F508del-CFTR (cystic …

[PDF][PDF] An examination of the validity of existing empirical formulae for the calculation of Ms temperature

CY Kung, JJ Rayment - 1981 - escholarship.org
CY Kung and JJ Rayment· When examining phase transformations in ferrous systems, it is
often desirable to have prior knowledge of the martensite start temperature·(Ms). In the area of…

Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One F508del Allele

…, E McKone, B Ramsey, JH Rayment… - American journal of …, 2023 - atsjournals.org
Rationale: Elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) has been shown to be safe and
effective in people with cystic fibrosis (CF) aged ⩾6 years with at least one F508del-CFTR …

Protocols for multi‐site trials using hyperpolarized 129Xe MRI for imaging of ventilation, alveolar‐airspace size, and gas exchange: A position paper from the 129Xe …

…, M Castro, RL Eddy, JH Rayment… - Magnetic resonance …, 2021 - Wiley Online Library
Hyperpolarized (HP) 129 Xe MRI uniquely images pulmonary ventilation, gas exchange,
and terminal airway morphology rapidly and safely, providing novel information not possible …

The global SMP fitness framework: A guide for leaders exploring the relevance of spirituality in the workplace

JA Smith, JJ Rayment - Management Decision, 2007 - emerald.com
Purpose – Although there is a growing emphasis on the importance of spirituality in the
workplace, the majority of calls for leaders to consider the spiritual dimension fail to offer …

The effect of inhaled hypertonic saline on lung structure in children aged 3–6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled …

…, C Prentice, T Pressler, JH Rayment… - The lancet Respiratory …, 2022 - thelancet.com
Background In the Saline Hypertonic in Preschoolers (SHIP) study, inhaled 7% hypertonic
saline improved the lung clearance index in children aged 3–6 years with cystic fibrosis, but it …

[HTML][HTML] Correlation of Lung Clearance Index with Hyperpolarized 129Xe Magnetic Resonance Imaging in Pediatric Subjects with Cystic Fibrosis

…, K Kowalik, B Zanette, JH Rayment… - American journal of …, 2017 - atsjournals.org
Methods This study was approved by the research ethics board at the Hospital for Sick
Children (research ethics board approval no. 1000048243).(Clinical trial registered with www. …